These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

866 related articles for article (PubMed ID: 33878826)

  • 21. The value of intravoxel incoherent motion and diffusion kurtosis imaging in the assessment of tumor regression grade and T stages after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
    Yang L; Xia C; Zhao J; Zhou X; Wu B
    Eur J Radiol; 2021 Mar; 136():109504. PubMed ID: 33421885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Locally advanced rectal cancer: predicting non-responders to neoadjuvant chemoradiotherapy using apparent diffusion coefficient textures.
    Liu M; Lv H; Liu LH; Yang ZH; Jin EH; Wang ZC
    Int J Colorectal Dis; 2017 Jul; 32(7):1009-1012. PubMed ID: 28497403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diffusion-weighted imaging: Apparent diffusion coefficient histogram analysis for detecting pathologic complete response to chemoradiotherapy in locally advanced rectal cancer.
    Choi MH; Oh SN; Rha SE; Choi JI; Lee SH; Jang HS; Kim JG; Grimm R; Son Y
    J Magn Reson Imaging; 2016 Jul; 44(1):212-20. PubMed ID: 26666560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Predictive Value of Pre-/Postneoadjuvant Chemoradiotherapy MRI Characteristics for Patient Outcomes in Locally Advanced Rectal Cancer.
    Meng Y; Wan L; Zhang C; Wang C; Ye F; Li S; Zou S; Cheng J; Xu K; Zhou C; Zhang H
    Acad Radiol; 2020 Sep; 27(9):e233-e243. PubMed ID: 31780392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of High-Resolution DWI in Combination With Texture Analysis for the Evaluation of Tumor Response After Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer.
    Yang L; Qiu M; Xia C; Li Z; Wang Z; Zhou X; Wu B
    AJR Am J Roentgenol; 2019 Jun; 212(6):1279-1286. PubMed ID: 30860889
    [No Abstract]   [Full Text] [Related]  

  • 26. Predicting the pathological response to chemoradiotherapy of non-mucinous rectal cancer using pretreatment texture features based on intravoxel incoherent motion diffusion-weighted imaging.
    Liu S; Wen L; Hou J; Nie S; Zhou J; Cao F; Lu Q; Qin Y; Fu Y; Yu X
    Abdom Radiol (NY); 2019 Aug; 44(8):2689-2698. PubMed ID: 31030244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prognosis and complications of local excision for rectal cancer after neoadjuvant chemoradiotherapy].
    Li YH; Qiu XY; Lin GL; Zhou JL; Xiao Y; Qiu HZ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr; 24(4):344-351. PubMed ID: 33878824
    [No Abstract]   [Full Text] [Related]  

  • 28. Quantitative synthetic MRI for predicting locally advanced rectal cancer response to neoadjuvant chemoradiotherapy.
    Lian S; Liu H; Meng T; Ma L; Zeng W; Xie C
    Eur Radiol; 2023 Mar; 33(3):1737-1745. PubMed ID: 36380196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple mathematical models of diffusion-weighted magnetic resonance imaging combined with prognostic factors for assessing the response to neoadjuvant chemotherapy and radiation therapy in locally advanced rectal cancer.
    Liang CY; Chen MD; Zhao XX; Yan CG; Mei YJ; Xu YK
    Eur J Radiol; 2019 Jan; 110():249-255. PubMed ID: 30599868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
    Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
    [No Abstract]   [Full Text] [Related]  

  • 31. Diffusion and perfusion MR parameters to assess preoperative short-course radiotherapy response in locally advanced rectal cancer: a comparative explorative study among Standardized Index of Shape by DCE-MRI, intravoxel incoherent motion- and diffusion kurtosis imaging-derived parameters.
    Fusco R; Sansone M; Granata V; Grimm R; Pace U; Delrio P; Tatangelo F; Botti G; Avallone A; Pecori B; Petrillo A
    Abdom Radiol (NY); 2019 Nov; 44(11):3683-3700. PubMed ID: 30361867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive value of modified MRI-based split scar sign (mrSSS) score for pathological complete response after neoadjuvant chemoradiotherapy for patients with rectal cancer.
    Yuan Y; Zheng K; Zhou L; Chen F; Zhang S; Lu H; Lu J; Shao C; Meng R; Zhang W; Gao X; Shen F
    Int J Colorectal Dis; 2023 Feb; 38(1):40. PubMed ID: 36790595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results.
    Lambrecht M; Vandecaveye V; De Keyzer F; Roels S; Penninckx F; Van Cutsem E; Filip C; Haustermans K
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):863-70. PubMed ID: 21398048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of Circulating Free DNA Fragmentomics in the Prediction of Pathological Response after Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
    Wang Y; Fan X; Bao H; Xia F; Wan J; Shen L; Wang Y; Zhang H; Wei Y; Wu X; Shao Y; Li X; Xu Y; Cai S; Zhang Z
    Clin Chem; 2023 Jan; 69(1):88-99. PubMed ID: 36308331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diffusion-weighted MRI and
    Xu X; Sun ZY; Wu HW; Zhang CP; Hu B; Rong L; Chen HY; Xie HY; Wang YM; Lin HP; Bai YR; Ye Q; Ma XM
    Radiat Oncol; 2021 Jul; 16(1):132. PubMed ID: 34281566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A prediction model of pathological complete response in patients with locally advanced rectal cancer after PD-1 antibody combined with total neoadjuvant chemoradiotherapy based on MRI radiomics].
    Zhang XY; Zhu HT; Li XT; Li YJ; Li ZW; Wang WH; Wu AW; Sun YS; Zhang L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Mar; 25(3):228-234. PubMed ID: 35340172
    [No Abstract]   [Full Text] [Related]  

  • 37. Intravoxel incoherent motion diffusion-weighted imaging for discriminating the pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Lu W; Jing H; Ju-Mei Z; Shao-Lin N; Fang C; Xiao-Ping Y; Qiang L; Biao Z; Su-Yu Z; Ying H
    Sci Rep; 2017 Aug; 7(1):8496. PubMed ID: 28819296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MRI-Based Radiomic Models Outperform Radiologists in Predicting Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
    Wen L; Liu J; Hu P; Bi F; Liu S; Jian L; Zhu S; Nie S; Cao F; Lu Q; Yu X; Liu K
    Acad Radiol; 2023 Sep; 30 Suppl 1():S176-S184. PubMed ID: 36739228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Locally advanced rectal cancer: qualitative and quantitative evaluation of diffusion-weighted magnetic resonance imaging in restaging after neoadjuvant chemo-radiotherapy.
    Napoletano M; Mazzucca D; Prosperi E; Aisa MC; Lupattelli M; Aristei C; Scialpi M
    Abdom Radiol (NY); 2019 Nov; 44(11):3664-3673. PubMed ID: 31004202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MRI-based radiomic score increased mrTRG accuracy in predicting rectal cancer response to neoadjuvant therapy.
    Miranda J; Horvat N; Assuncao AN; de M Machado FA; Chakraborty J; Pandini RV; Saraiva S; Nahas CSR; Nahas SC; Nomura CH
    Abdom Radiol (NY); 2023 Jun; 48(6):1911-1920. PubMed ID: 37004557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.